Pancreatic neuroendocrine neoplasms include mainly well-differentiated neuroendocrine
tumors but also rare poorly differentiated neuroendocrine carcinomas. Molecular …

Gastroenteropancreatic endocrine tumors (GEP-NETs) are relatively uncommon; comprising
approximately 0.5% of all human cancers. Although they often exhibit relatively indolent …

Purpose: We aimed to test whether α-internexin could be a molecular biomarker of tumor
aggressiveness and prognosis in pancreatic neuroendocrine tumors (PNETs). Patients and …

Aim: To investigate frequent quantitative alterations of intestinal-type gastric
adenocarcinoma. Materials and Methods: We analyzed genome-wide DNA copy numbers of …

Pancreatic neuroendocrine tumors (PNETs) share a unique genetic identity, functional
behavior, and clinical course. Compared with tumors of the exocrine pancreas, they are rare …

Представлены современные взгляды на диагностику и лечение синдрома Золлингера-
Эллисона (СЗЭ). Подчеркивается важность включения СЗЭ в круг дифференциальной …

Since chemotherapy started in 1940s, chemosensitivity testing has been both a very
attractive field and one fraught with potential pitfalls. Many methods were developed and …

CASE REPORT Dr. Shoushtari: A 47-year-old woman presented with 3 years of intermittent
back pain radiating to the abdomen and 2 months of fatigue, abdominal distension, and mild …

The pathogenesis of sporadic pancreatic neuroendocrine neoplasms (PNENs) is poorly
understood. To gain insight into the genetic mechanisms underlying this tumor entity, we …

Pancreatic neuroendocrine tumors (PNETs) are a heterogeneous group of neoplasms that
are the second most common among pancreatic neoplasms. Treatment of PNETs appears to …